NEUROPHET Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	4,043	4,102	3,017
Short-Term Investments	14,696	19,667	3,000
Cash & Short-Term Investments	18,739	23,768	6,017
Cash Growth	-	295.00%	-
Accounts Receivable	445.8	223.17	353.94
Other Receivables	283.28	226.49	96.29
Receivables	729.08	449.67	450.23
Inventory	55.74	47.24	10.86
Prepaid Expenses	206.28	227.65	54.99
Other Current Assets	255.61	521.61	354.34
Total Current Assets	19,985	25,015	6,888
Property, Plant & Equipment	1,394	1,275	1,992
Long-Term Investments	0	0	-0
Other Intangible Assets	398.97	434.33	470.29
Other Long-Term Assets	183.95	160.99	510.25
Total Assets	21,962	26,884	9,860
Accrued Expenses	694.05	455.83	364.47
Short-Term Debt	-	4,804	3,522
Current Portion of Leases	486.03	686	625.07
Other Current Liabilities	1,304	991.74	30,963
Total Current Liabilities	2,484	6,937	35,474
Long-Term Leases	38.37	40.56	665.06
Other Long-Term Liabilities	445.12	454.44	616.24
Total Liabilities	2,968	7,432	36,755
Common Stock	12,092	11,637	3,691
Additional Paid-In Capital	90,441	85,611	105.01
Retained Earnings	-83,991	-78,249	-55,860
Comprehensive Income & Other	453.25	453.81	867.16
Total Common Equity	18,995	19,452	-51,197
Shareholders' Equity	18,995	19,452	-26,895
Total Liabilities & Equity	21,962	26,884	9,860
Total Debt	524.4	5,530	4,812
Net Cash (Debt)	18,214	18,238	1,206
Net Cash Growth	-	1412.64%	-
Net Cash Per Share	1648.96	1875.00	326.63
Filing Date Shares Outstanding	11.96	11.64	3.69
Total Common Shares Outstanding	11.96	11.64	3.69
Working Capital	17,501	18,077	-28,586
Book Value Per Share	1587.92	1671.64	-13869.37
Tangible Book Value	18,596	19,018	-51,667
Tangible Book Value Per Share	1554.57	1634.32	-13996.77
Machinery	1,082	1,035	869.74